These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 6125092

  • 1. Cyclic nucleotide phosphodiesterase activity in patients with obstructive airways disease.
    Polson JB, Krzanowski JJ, Goldman AL, Szentivanyi A.
    Allergol Immunopathol (Madr); 1982; 10(2):101-4. PubMed ID: 6125092
    [Abstract] [Full Text] [Related]

  • 2. [Kinetic properties and regulation of cyclic nucleotide phosphodiesterases in lymphoid cells].
    Azhaeva EV, Severin ES.
    Bioorg Khim; 1987 Sep; 13(9):1157-63. PubMed ID: 2827690
    [Abstract] [Full Text] [Related]

  • 3. [Modern representations of multiple forms of cyclic nucleotide phosphodiesterases in mammalian tissues].
    Medvedeva MV.
    Biokhimiia; 1995 Mar; 60(3):364-86. PubMed ID: 7734612
    [Abstract] [Full Text] [Related]

  • 4. Cyclic nucleotides and cyclic nucleotide phosphodiesterases in kidneys from rats with experimental diabetes.
    Hoskins B, Luong HB.
    Res Commun Chem Pathol Pharmacol; 1981 Aug; 33(2):381-4. PubMed ID: 6272381
    [Abstract] [Full Text] [Related]

  • 5. Role of cyclic AMP- and cyclic GMP-phosphodiesterases in the control of cyclic nucleotide levels and smooth muscle tone in rat isolated aorta. A study with selective inhibitors.
    Schoeffter P, Lugnier C, Demesy-Waeldele F, Stoclet JC.
    Biochem Pharmacol; 1987 Nov 15; 36(22):3965-72. PubMed ID: 2825708
    [Abstract] [Full Text] [Related]

  • 6. [Phosphodiesterases of cyclic GMP].
    Wróblewska H, Gorczyca WA.
    Postepy Hig Med Dosw; 2001 Nov 15; 55(5):611-27. PubMed ID: 11795198
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of hamster adipocyte cyclic 3':5'-nucleotide phosphodiesterase activity by ionophore A23187 and calcium.
    Nemecek GM.
    J Cyclic Nucleotide Res; 1978 Aug 15; 4(4):299-309. PubMed ID: 214467
    [Abstract] [Full Text] [Related]

  • 8. Modulation of rat thymocyte proliferative response through the inhibition of different cyclic nucleotide phosphodiesterase isoforms by means of selective inhibitors and cGMP-elevating agents.
    Marcoz P, Prigent AF, Lagarde M, Nemoz G.
    Mol Pharmacol; 1993 Nov 15; 44(5):1027-35. PubMed ID: 8246905
    [Abstract] [Full Text] [Related]

  • 9. Correlation of granulocyte intracellular activities of cyclic nucleotide phosphodiesterases with leukocyte count in patients with chronic myelogenous leukaemia.
    Naskalski JW, Uciński WS.
    Haematologia (Budap); 1986 Nov 15; 19(4):285-92. PubMed ID: 3028917
    [Abstract] [Full Text] [Related]

  • 10. [The process of cyclic adenosine-3',5'-monophosphate phosphodiesterase activation by 2',5'-oligoadenylate].
    Tunitskaia VL, Itkes AV, Kochetkova MN, Severin ES.
    Biokhimiia; 1983 Oct 15; 48(10):1721-5. PubMed ID: 6315087
    [Abstract] [Full Text] [Related]

  • 11. Specific effects of n-3 fatty acids and 8-bromo-cGMP on the cyclic nucleotide phosphodiesterase activity in neonatal rat cardiac myocytes.
    Picq M, Dubois M, Grynberg A, Lagarde M, Prigent AF.
    J Mol Cell Cardiol; 1996 Oct 15; 28(10):2151-61. PubMed ID: 8930810
    [Abstract] [Full Text] [Related]

  • 12. [Cyclic AMP-specific nucleotide phosphodiesterase from the insoluble fraction of the human brain].
    Kireeva NN, Bobruskin ID, Severin SE.
    Biokhimiia; 1995 May 15; 60(5):694-708. PubMed ID: 7662796
    [Abstract] [Full Text] [Related]

  • 13. Regulation by a beta-adrenergic receptor of a Ca2+-independent adenosine 3',5'-(cyclic)monophosphate phosphodiesterase in C6 glioma cells.
    Onali P, Schwartz JP, Hanbauer I, Costa E.
    Biochim Biophys Acta; 1981 Jul 15; 675(2):285-92. PubMed ID: 6268187
    [Abstract] [Full Text] [Related]

  • 14. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1559-67. PubMed ID: 15041473
    [Abstract] [Full Text] [Related]

  • 15. Regulation of cyclic nucleotide phosphodiesterase activity in rhesus fetal muscle.
    Beatty CH, Herrington PT, Bocek RM.
    Biol Neonate; 1977 Apr 15; 32(1-2):33-42. PubMed ID: 198031
    [Abstract] [Full Text] [Related]

  • 16. Cyclic nucleotide phosphodiesterase of normal and leukemic lymphocytes. Kinetic properties and selective alteration of the activity of the multiple molecular forms.
    Hait WN, Weiss B.
    Mol Pharmacol; 1979 Nov 15; 16(3):851-64. PubMed ID: 231197
    [No Abstract] [Full Text] [Related]

  • 17. Aggregation states of cyclic nucleotide phosphodiesterase of murine thymocytes.
    Sobolev AS, Rybalkin SD.
    Cell Biochem Funct; 1986 Jul 15; 4(3):205-11. PubMed ID: 3015450
    [Abstract] [Full Text] [Related]

  • 18. Multiple cyclic nucleotide phosphodiesterases in human trabecular meshwork cells.
    Zhou L, Thompson WJ, Potter DE.
    Invest Ophthalmol Vis Sci; 1999 Jul 15; 40(8):1745-52. PubMed ID: 10393044
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase inhibitors in airways disease.
    Fan Chung K.
    Eur J Pharmacol; 2006 Mar 08; 533(1-3):110-7. PubMed ID: 16458289
    [Abstract] [Full Text] [Related]

  • 20. Effects of fatty acids on activity of cGMP-stimulated cyclic nucleotide phosphodiesterase from calf liver.
    Yamamoto T, Yamamoto S, Manganiello VC, Vaughan M.
    Arch Biochem Biophys; 1984 Feb 15; 229(1):81-9. PubMed ID: 6322693
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.